Leukemia: Beneficial actions of retinoids and rexinoids

International Journal of Biochemistry and Cell Biology

Volumn 36, Issue 2, 2004, Pages 178-182

  Altucci, Lucia ^a   Wilhelm, Emmanuelle ^b   Gronemeyer, Hinrich ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Apoptosis; Leukemia; RAR; Retinoid; Rexinoid; RXR

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; CELL NUCLEUS RECEPTOR; HISTONE DEACETYLASE INHIBITOR; HYBRID PROTEIN; ONCOPROTEIN; PHOSPHODIESTERASE INHIBITOR; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN KINASE A AGONIST; RECEPTOR; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOID; RETINOID X RECEPTOR; REXINOID; REXINOID RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER GROWTH; CANCER RECURRENCE; CANCER REGRESSION; CELL DIFFERENTIATION; CELL GROWTH; CELL SURVIVAL; CHROMOSOME TRANSLOCATION; COMBINATION CHEMOTHERAPY; COMPLEX FORMATION; HUMAN; LEUKEMIA; NONHUMAN; PROMYELOCYTE; PROMYELOCYTIC LEUKEMIA; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; WILD TYPE;

GOES;

EID: 0345276716     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(03)00247-4     Document Type: Short Survey

References (16)

1. Altucci L., Gronemeyer H. The promise of retinoids to fight against cancer. Nature Reviews Cancer. 1(3):2001;181-193.
2. Altucci L., Rossin A., Raffelsberger W., Reitmair A., Chomienne C., Gronemeyer H. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nature Medicine. 7(6):2001;680-686.
3. Benoit G., Altucci L., Flexor M., Ruchaud S., Lillehaug J., Raffelsberger W., Gronemeyer H., Lanotte M. RAR-independent RXR signaling induces t(15; 17) leukemia cell maturation. The EMBO Journal. 18(24):1999;7011-7018.
4. Benoit G.R., Flexor M., Besancon F., Altucci L., Rossin A., Hillion J., Balajthy Z., Legres L., Segar-Bendirdjian E., Gronemeyer H., Lanotte M. Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells. Molecular Endocrinology. 15:2001;1154-1169.
5. Bourget W., Germain P., Gronemeyer H. Nuclear receptor ligand-binding domains: Three-dimensional structures, molecular interactions and pharmacological implications. Trends in Pharmacological Sciences. 21(10):2000;381-388.
6. Ferrara F.F., Fazi F., Bianchini A., Padula F., Gelmetti V., Minucci S., Mancini M., Pelicci P.G., Lo Coco F., Nervi C. Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukaemia. Cancer Research. 61:2001;2-7.
7. Germain P., Iyer J., Zechel C., Gronemeyer H. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature. 415(6868):2002;187-192.
8. Guillemin M.C., Raffoux E., Vitoux D., Kogan S., Soilihi H., Lallemand-Breitenbach V., Zhu J., Janin A., Daniel M.T., Gourmel B., Degos L., Dombret H., Lanotte M., de The H. In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia. Journal of Experimental Medicine. 196(10):2002;1373-1380.
9. He L.Z., Guidez F., Tribioli C., Peruzzi D., Ruthardt M., Zelent A., Pandolfi P.P. Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL. Natural Genetics. 18(2):1998;126-135.
10. Launay, S., Giannì, M., Diomede, L., Machesky, L. M., Enouf, J., & Papp, B. (2002). Enhancement of ATRA-induced cell differentiation by inhibition of calcium accumulation into the endoplasmic reticulum. Cross-talk between RARα and calcium-dependent signaling. Blood, 101(8), 3220-3228 (Epub 2002 Dec. 19).
11. Lin R.J., Evans R.M. Acquisition of oncogenic potential by RAR chimer as in acute promyelocytic leukemia through formation of homodimers. Molecular Cell. 5(5):2000;821-830.
12. Minucci S., Maccarana M., Cioce M., De Luca P., Gelmetti V., Segalla S., Di Croce L., Giavara S., Matteucci C., Gobbi A., Bianchini A., Colombo E., Schiavoni I., Badaracco G., Hu X., Lazar M.A., Landsberger N., Nervi C., Pellicci P.G. Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation. Molecular Cell. 5(5):2000;811-820.
13. Pisano C., Kollar P., Gianni M., Kalac Y., Giordano V., Ferrara F.F., Tancredi R., Devoto A., Rinaldi A., Rambaldi A., Penco S., Marzi M., Moretti G., Vesci L., Tinti O., Carminati P., Terao M., Garattini E. Bis-indols: A novel class of molecules enhancing the cytodifferentiating properties of retinoids in myeloid leukemia cells. Blood. 100(10):2002;3719-3730.
14. Salomoni P., Pandolfi P.P. The role of PML in tumor suppression. Cell. 108:2002;165-170.
15. Tallman M.S., Nabhan C., Feusner J.H., Rowe J.M. Acute promyelocytic leukemia: Evolving therapeutic strategies. Blood. 99:2002;759-767.
16. Zelent A., Guidez F., Melnick A., Waxman S., Licht J.D. Translocations of the RARα gene in acute promyelocytic leukemia. Oncogene. 20:2001;7186-7203.